CGRIX
Price
$67.65
Change
-$1.81 (-2.61%)
Updated
Mar 3 closing price
Net Assets
1.56B
GFACX
Price
$63.16
Change
-$1.29 (-2.00%)
Updated
Mar 3 closing price
Net Assets
298.54B
Ad is loading...

CGRIX vs GFACX

Header iconCGRIX vs GFACX Comparison
Open Charts CGRIX vs GFACXBanner chart's image
Calamos Growth I
Price$67.65
Change-$1.81 (-2.61%)
VolumeN/A
Net Assets1.56B
American Funds Growth Fund of Amer C
Price$63.16
Change-$1.29 (-2.00%)
VolumeN/A
Net Assets298.54B
CGRIX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CGRIX vs. GFACX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRIX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 299B vs. CGRIX (1.56B). CGRIX (0.00) and GFACX (0.00) have matching dividends . CGRIX was incepted earlier than GFACX: CGRIX (27 years) vs GFACX (24 years). CGRIX is a more actively managed with annual turnover of: 57.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than CGRIX: GFACX (250) vs CGRIX (1000000). CGRIX annual gain was more profitable for investors over the last year : 9.87 vs. GFACX (3.95). CGRIX return over 5 years is better than : 55.48 vs. GFACX (35.30).
CGRIXGFACXCGRIX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD-3.974-0.941422%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B299B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.873.95250%
Returns for 3 years31.3314.82211%
Returns for 5 years55.4835.30157%
Returns for 10 years34.3951.1067%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERT11.94-0.04
-0.33%
Certara
CHWY35.90-1.36
-3.65%
Chewy
SMWB9.11-0.43
-4.51%
Similarweb Ltd
NVCT6.20-0.49
-7.32%
Nuvectis Pharma
LIDR0.58-0.05
-8.57%
AEye